A phase I dose escalation study of GCC19CART: A novel CoupledCAR therapy for subjects with metastatic colorectal cancer

作者全名："Cui, J.; Chen, N.; Pu, C.; Zhao, L.; Li, N.; Wang, C.; Huang, Y.; Luo, S.; Li, X.; Yang, Z.; Bie, J.; Zhu, R.; Tang, H.; Liang, T.; Wang, Y.; Lu, V.; Wu, Z.; Song, Y.; Xiao, L."

作者地址："[Cui, J.; Wang, C.] First Hosp Jilin Univ, Ctr Oncol, Changchun, Peoples R China; [Chen, N.; Zhao, L.; Liang, T.; Wang, Y.] Jilin Univ, Ctr Oncol, Bethune Hosp 1, Changchun, Peoples R China; [Pu, C.; Zhu, R.; Wu, Z.] Innovat Cellular Therapeut, R&D, Shanghai, Peoples R China; [Li, N.] Zhengzhou Univ, Med Oncol, Henan Canc Hosp, Affiliated Canc Hosp, Zhengzhou, Peoples R China; [Huang, Y.] Chongqing Med Univ, Affiliated Hosp 2, Oncol Ctr, Chongqing, Peoples R China; [Luo, S.] Zhengzhou Univ, Oncol Ctr, Henan Canc Hosp, Affiliated Canc Hosp, Zhengzhou, Peoples R China; [Li, X.] Lanzhou Univ, Hosp 1, Oncol Ctr, Sch Clin Med 1, Lanzhou, Peoples R China; [Yang, Z.] Chongqing Med Univ, Ctr Oncol, Chongqing, Peoples R China; [Bie, J.] Nanchong Cent Hosp, Oncol Ctr, Nanchong, Peoples R China; [Tang, H.] Innovat Cellular Therapeut, M&F, Shanghai, Peoples R China; [Lu, V.] Innovat Cellular Therapeut Inc, QA, Rockville, MD USA; [Song, Y.] Zhengzhou Univ, Oncol Ctr, Affiliated Canc Hosp, Zhengzhou, Peoples R China; [Song, Y.] Henan Canc Hosp, Zhengzhou, Peoples R China; [Xiao, L.] Innovat Cellular Therapeut Inc, Oncol Ctr, Rockville, MD USA"

通信作者：　

来源：ANNALS OF ONCOLOGY

ESI学科分类：CLINICAL MEDICINE

WOS号：WOS:001087480200627

JCR分区：Q1

影响因子：50.5

年份：2023

卷号：34

期号：　

开始页：S453

结束页：S453

文献类型：Meeting Abstract

关键词：　

摘要：　

基金机构：Innovative Cellular Therapeutics

基金资助正文：Innovative Cellular Therapeutics.